Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Response to comment on Brunnekreef et al.: Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?

Brunnekreef JJ, Schreurs BW.

Int Orthop. 2013 Aug;37(8):1631. doi: 10.1007/s00264-013-1948-8. No abstract available.

2.

Comment on Brunnekreef et al.: Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?

Zhang H, Guo W, Zhang KN, Lou ZY.

Int Orthop. 2013 Aug;37(8):1629. doi: 10.1007/s00264-013-1943-0. Epub 2013 Jun 5. No abstract available.

3.

Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?

Brunnekreef JJ, Hoogervorst P, Ploegmakers MJ, Rijnen WH, Schreurs BW.

Int Orthop. 2013 Apr;37(4):583-7. doi: 10.1007/s00264-013-1781-0. Epub 2013 Jan 29.

4.

Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.

Winkler S, Springorum HR, Vaitl T, Handel M, Barta S, Kehl V, Craiovan B, Grifka J.

Int Orthop. 2016 Apr;40(4):673-80. doi: 10.1007/s00264-015-3077-z. Epub 2016 Jan 4.

PMID:
26728611
5.

Rofecoxib inhibits heterotopic ossification after total hip arthroplasty.

van der Heide HJ, Koorevaar RC, Lemmens JA, van Kampen A, Schreurs BW.

Arch Orthop Trauma Surg. 2007 Sep;127(7):557-61. Epub 2006 Nov 16.

PMID:
17106714
6.

Preoperative cyclooxygenase-2 inhibitor treatment reduces the incidence of heterotopic ossification after hip arthroplasty: six-month follow-up.

Buvanendran A, Kroin JS, Berger RA.

Anesthesiology. 2007 Aug;107(2):358-9. No abstract available.

PMID:
17667588
7.

Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.

van der Heide HJ, Rijnberg WJ, Van Sorge A, Van Kampen A, Schreurs BW.

Acta Orthop. 2007 Feb;78(1):90-4.

PMID:
17453398
8.

Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment.

Dorn U, Grethen C, Effenberger H, Berka H, Ramsauer T, Drekonja T.

Acta Orthop Scand. 1998 Apr;69(2):107-10.

PMID:
9602763
9.

Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey.

Barbato M, D'Angelo E, Di Loreto G, Menna A, Di Francesco A, Salini V, Zoppi U, Cavasinni L, La Floresta P, Romanò CL.

J Orthop Traumatol. 2012 Jun;13(2):63-7. doi: 10.1007/s10195-012-0180-4. Epub 2012 Feb 23.

10.

Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial.

Saudan M, Saudan P, Perneger T, Riand N, Keller A, Hoffmeyer P.

J Bone Joint Surg Br. 2007 Feb;89(2):155-9.

12.

Aspirin decreases heterotopic ossification after hip resurfacing.

Nunley RM, Zhu J, Clohisy JC, Barrack RL.

Clin Orthop Relat Res. 2011 Jun;469(6):1614-20. doi: 10.1007/s11999-011-1846-6.

14.

Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin?

Vasileiadis GI, Sakellariou VI, Kelekis A, Galanos A, Soucacos PN, Papagelopoulos PJ, Babis GC.

J Musculoskelet Neuronal Interact. 2010 Jun;10(2):159-65.

15.

Inter-observer reliability in the assessment of heterotopic ossification: proposal of a combined classification.

Toom A, Fischer K, Märtson A, Rips L, Haviko T.

Int Orthop. 2005 Jun;29(3):156-9. Epub 2005 Apr 13.

16.

No effective prophylaxis of heterotopic ossification with short-term ibuprofen.

Koorevaar CT, Hu HP, Lemmens A, van Kampen A.

Arch Orthop Trauma Surg. 1999;119(3-4):183-5.

PMID:
10392515
17.
18.

[Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].

Liu HP, Li YJ, Wang CX, Li SH, Zhao ZW, Wang JH.

Zhongguo Gu Shang. 2011 Oct;24(10):857-60. Chinese.

PMID:
22097138
19.

Effect of a selective COX-2 inhibitor, celecoxib, on heterotopic ossification after total hip arthroplasty: a case-controlled study.

Oni JK, Pinero JR, Saltzman BM, Jaffe FF.

Hip Int. 2014 May-Jun;24(3):256-62. doi: 10.5301/hipint.5000109. Epub 2014 Jan 28.

PMID:
24474408
20.

Heterotopic ossification in patients after total hip replacement.

Stołtny T, Koczy B, Wawrzynek W, Miszczyk L.

Ortop Traumatol Rehabil. 2007 May-Jun;9(3):264-72. Review. English, Polish.

PMID:
17721424

Supplemental Content

Support Center